We describe a rosette-forming glioneuronal tumour (RGNT) of the 4th ventricle in a 41 year-old man with neurofibromatosis type 1 (NF1). This patient had a family history of NF1 and presented with café-au-lait spots and multiple neurofibromata. At the age of 16 years (1983) , he presented with severe headache and the head computed tomogram (CT) scan showed a 4th ventricular mass. The mass was partially resected and the histology was initially reported as a low grade astrocytoma. The patient died at age 41 years.
The smear cytology from the original biopsy 25 years ago, showed a biphasic lesion composed of piloid cells with elongated fibrillary processes accompanied by Rosenthal fibers, and small round cells with finely granular nuclear chromatin forming rare neurocytic rosette (Figure 1a (Figure 2e ). There were frequent plaques with amyloid core in the temporal and cingulate cortices. These were highlighted by the Bielschowsky and Congo red stains as well as by amyloid precursor protein and beta-amyloid immunohistochemistry. However, no neuritic plaques or tau positive neurofibrillary tangles were seen.
Rosette-forming glioneuronal tumour of the fourth ventricle, which is included as a grade I tumour in the recent World Health Organization classification of central nervous system tumours 1 , was first described as a cerebellar form of dysembryoplastic neuroepithelial tumour in 1995 2 . Subsequently, Komori et al introduced the term RGNT of the fourth ventricle in their description of 11 patients in 2002 3 . In the English literature, there are 47 cases reported so far 4 . These cases showed tumour predilection for young adults with the mean age of about 30 years and female predominance (31 Female (F), 16 Male (M)). Most of the symptomatic cases presented with clinical features of increased intracranial pressure (i.e. headache, nausea, vomiting). Ataxia, vertigo, and cranial nerve palsies had been reported occasionally, and rarely seizures, nystagmus and hyperacusis as well. The MRIs in most cases showed solid and cystic lesions around the fourth ventricle, which were isointense or hypointense on T1-weighted images and hyperintense on T2-weighted images with variable enhancement. This tumour is characterized by the presence of the biphasic components (neuronal and glial). The glial portion of this tumour for the majority (25 out of 47 reported cases) resembles pilocytic astrocytoma (PA) including: piloid cells with hair-like cytoplasmic processes, microcytic matrix, Rosenthal fibers, eosinophilic granular bodies, and microcalcification. The neuronal component consists of uniform neurocytes forming rosettes and/or perivascular pseudorosettes. Anaplastic features such as mitoses, necrosis or endothelial proliferation have not been reported 1 . The literature revealed no evidence of clinical recurrence except for two cases treated with post-surgical radiation, despite the fact that about half of these tumours have not been completely resected.
Rosette-forming glioneuronal tumour has only been reported once previously in association with NF1, however that particular tumour was located in the chiasmal optic nerve and not the fourth ventricular region 5 . Apart from its unusual location, this tumour showed the typical histological features of RGNT. Since the association with NF1 is documented in two (including our case) of the 47 (4.25%) reported cases, we believe this may not be purely coincidental. Although the tumour in our patient followed a benign clinical course of 25 years, the microscopic findings based on autopsy material showed the persistence of an infiltrative glial component consistent with its neoplastic nature. In spite of its indolent nature, this tumor bore no resemblance to previously described hamartoma or developmental anomalies in the same region 6 . As far as we know, this is the first documented case in the English literature of a RGNT located at the fourth ventricular region in a NF1 patient. 
